Preliminary Program

Preliminary program:                                                                                   Click here to download

May 3rd 2018

10:30-11:30 Registration
11:30-12:30 Lunch
12:30-12:40 Welcome/opening words
Ole Solheim
12:40-13:25 From temozolomide to tumor treating fields in the treatment of glioma – a journey of successes and failures
Roger Stupp
13:25-13:45 Truly individualized chemotherapy for glioblastoma – strategies and challenges
Einar Vik-Mo
13:45-14:15 Abstract session 1 (3 abstracts)
14:15-14:45 Coffee Break
14:45-15:30 The role of surgery for recurrent glioblastoma
Jörg Christian Tonn
15:30-15:50 Abstract session 2 (2 abstracts)
15:50-16:20 Break, refreshments
16:20-16:45 Management of low grade gliomas: What is known and what is not known?
Asgeir Jakola
16:45-17:10 Abstract session 3 (2 abstracts)
17:10-17:30 Does surgical resection improve survival in oligodendroglioma grade II and III?
Ole Solheim

May 4th 2018

08:30-9:15 Diffuse glioma growth; a guerilla war
Pieter Wesseling
9:15-09:45 Abstract Session 4 (3 abstracts)
09:45-10:15 Coffee break
10:15- 11:00 Concepts for precision immunotherapy
Wolfgang Wick
11:00-11:30 Abstract session 5 (3 abstracts)
11:30-12:00 Coffee break
12:00-12:20 Integrated glioma diagnostics with genome-wide methylation profiling
Bjarne Winther Kristense
12:20-12:50 Abstract session 6 (3 abstracts)
13:00-14:00 Lunch
14:00-14:20 Is PET imaging clinically useful in neuro-oncology?
Ian Law
14:20-15:00 Abstract session 7 (4 abstracts)
15:00-15:15 Measuring tumor progression in glioblastoma, eyeballing, RANO, or volume segmentation?
Erik Magnus Berntsen
15:15-15:35 Coffee break
15:35-15:55 Cyber Knife in practical neuro-oncology
Juha Jääskeläinen
15:55-16:15 Proton beam therapy for glioma
Petra Witt Nyström
16:15-16:45 Break and refreshments
16:45-17:30 Valganciclovir, from lab to clinical trial
Cecilia Söderberg Nauclér
19:30-23:00 Conference dinner

May 5th 2018 

09:00-09:20 Survival benefit of glioblastoma treatment during the last ten years
Hans Skovgaard Poulsen
09:20-09:40 Optune – hype or hope?
Petter Brandal
09:40-10:00 Abstract session 8 (2 abstracts)
10:00-10:20 How do/should we inform patients about the disease and treatment?
Hanna Mäenpää
10:20-10:50 Coffee break
10:50- 11:10 Gender disparity in glioma
Anja Smits
11:10-11:30  Awake surgery: pro et con
Jannick Brennum vs. Ole Solheim
11:30-11:50 Abstract Session 9 (2 abstracts)
11:50- 12:10 External factors of importance in the management of brain tumours
Roger Henriksson
12:10-12:15 Closing words
Ole Solheim
12:15 – Lunch and departure


Pro et con debates
Two lecturers argue for opposite views concerning controversial topics in neuro-oncology